CryoCloud, a Utrecht, the Netherlands based biotech startup that developed a proprietary data analysis platform, closed a a €500k pre-seed funding round.
The round was led by Nina Capital, with participation from Utrecht Health Seed Fund and ROM Utrecht Region.
Co-founded in 2021 by Robert Englmeier, Ilja Gubins, and Boy Persoon, CryoCloud provides a cloud-based cryoEM data analysis platform that enables the fast and scalable determination of 3D protein structures used for drug discovery. The company has progressed from its conceptual stages, through various accelerator programs, to the launch the analysis platform designed to allow scientists to determine protein structures experimentally and visualise relevant targets in their native or drug-bound state.
CryoCloud will use the funds to expand the capabilities of its platform.
FinSMEs
29/02/2024